Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Generic Hetlioz Does Not Require Braille Labeling, FDA Tells Vanda
Jul 25 2023
•
By
Brenda Sandburg
The FDA says braille is not required in labeling for generic versions of the sleep disorder drug Hetlioz. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics